Template condensation on iron(II) ion of dichloroglyoxime (H2C12Gm) with (C6H5O)3, n-C4H9B(O-n-C4H9)2, and BF3.O(C2H5)2 in CH3NO2 afforded reactive clathrochelate precursors Fe(C12Gm)3(BC6H5)2 (2), Fe(C12Gm)3(B-n-C4H9)2 (3), and Fe(C12Gm)3(BF)2 (4). A series of triribbed-functionalized clathrochelate dioximates have been synthesized. Reaction of 2 with C6H5SH/K2CO3 and CH3SH/t-C4H9OK in 1,4-dioxane and THF afforded Fe((C6H5S)2Gm)3(BC6H5)2 (5) and Fe((CH3S)2Gm)3(BC6H5)2 (6). Reaction of 3 with C6H5OK in THF afforded Fe((C6H5O)2Gm)3(B-n-C4H9)2 (7). Condensation of 3 with bis(2-(o-oxyphenoxy))diethyl ether in THF afforded di- and tricrown etheric Fe(CwGm)2(C12Gm)(Bn-C4H9)2 (8) and Fe(CwGm)3(B-n-C4H9)2 (9) clathrochelates. Condensation of 3 with 3,5-dithiaoctane-1,8-dithiol/Cs2CO3 in DMF afforded the thiocrown etheric Fe((12anS4)Gm)3(BC6H5)2 complex (10). Reaction of 2 with n-butylamine in DMF resulted in the tetrasubstituted Fe((n-C4H9NH)2Gm)2(C12Gm)(BC6H5)2 clathrochelate (11). The clathrochelates obtained have been characterized both on the basis of elemental analysis, FAB and PD mass spectrometry, IR, UV-vis, 57Fe Mössbauer, and NMR spectroscopies and crystallographically (compounds 3, 4, 6, 7, and 11). An encapsulated iron(II) ion in a distorted trigonal-prismatic environment of six nitrogen atoms of the macrobicyclic ligand was found to be in a low-spin state. The cyclic voltammograms for the complexes 2-11 show irreversible oxidation waves assignable to Fe3+/Fe2+ couples. The correlation of E1/2 for these couples with Hammet sigma para constants for substituents in dioximate fragments has been demonstrated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.